Plus   Neg

AbbVie Boosts FY19 Adj. EPS Outlook - Quick Facts

While reporting financial results for the second quarter, biopharmaceutical company AbbVie Inc. (ABBV) on Friday raised its adjusted earnings guidance for the full-year 2019.

For fiscal 2019, AbbVie now projects adjusted earnings in a range of $8.82 to $8.92 per share, up from the prior guidance range of $8.73 to $8.83 per share.

On average, analysts polled by Thomson Reuters expect the company to report earnings of $8.82 per share for the year. Analysts' estimates typically exclude special items.

The company's 2019 adjusted earnings guidance excludes $3.13 per share of intangible asset amortization expense, non-cash charges for contingent consideration adjustments and other specified items.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Two companies have recalled Wintergreen Essential Oil saying the lack of child resistant packaging as required carries the risks of poisoning children, the U.S. Consumer Product Safety Commission stated. Waldo, Wisconsin - based Capstone Holdings LLC is calling back about 2,935 units of Simply Earth Wintergreen Essential Oil that were manufactured in the United States. The U.S. Food and Drug Administration approved Merck & Co. Inc.'s combination antibiotic Recarbrio for the expanded indication in the treatment of adults with hospital-acquired and ventilator-associated bacterial pneumonia (HABP/VABP). The drug had received initial approval in the U.S. in July 2019 to treat patients with complicated urinary tract infections and complicated intra-abdominal infecti Amazon is expanding the aircraft fleet of its air cargo network by leasing 12 additional Boeing 767-300 converted cargo aircraft from Air Transport Services Group Inc. This comes amid increased demand for shipments due to the coronavirus pandemic. These aircraft will join Amazon Air's existing fleet of 70 aircraft to bring its total network to more than 80 aircraft.
Follow RTT